These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 22551740
1. Risk factors for conversion to neovascular age-related macular degeneration based on longitudinal morphologic and visual acuity data. Friberg TR, Bilonick RA, Brennen PM. Ophthalmology; 2012 Jul; 119(7):1432-7. PubMed ID: 22551740 [Abstract] [Full Text] [Related]
2. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study. Silva R, Cachulo ML, Fonseca P, Bernardes R, Nunes S, Vilhena N, Faria de Abreu JR. Ophthalmologica; 2011 Jul; 226(3):110-8. PubMed ID: 21822000 [Abstract] [Full Text] [Related]
3. Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients. Friberg TR, Musch DC, Lim JI, Morse L, Freeman W, Sinclair S, PTAMD Study Group. Ophthalmology; 2006 Apr; 113(4):622.e1. PubMed ID: 16581422 [Abstract] [Full Text] [Related]
4. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial. Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research GroupCAPT Coordinating Center, University of Pennsylvania, Philadelphia, PA 19104-3309, USA.. Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512 [Abstract] [Full Text] [Related]
5. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Sunness JS, Gonzalez-Baron J, Applegate CA, Bressler NM, Tian Y, Hawkins B, Barron Y, Bergman A. Ophthalmology; 1999 Sep; 106(9):1768-79. PubMed ID: 10485549 [Abstract] [Full Text] [Related]
6. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Olk RJ, Friberg TR, Stickney KL, Akduman L, Wong KL, Chen MC, Levy MH, Garcia CA, Morse LS. Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341 [Abstract] [Full Text] [Related]
7. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Davis MD, Ferris FL, Age-Related Eye Disease Study Research Group. JAMA Ophthalmol; 2014 Mar; 132(3):272-7. PubMed ID: 24385141 [Abstract] [Full Text] [Related]
9. Risk of age-related macular degeneration 3 years after cataract surgery: paired eye comparisons. Wang JJ, Fong CS, Rochtchina E, Cugati S, de Loryn T, Kaushik S, Tan JS, Arnold J, Smith W, Mitchell P. Ophthalmology; 2012 Nov; 119(11):2298-303. PubMed ID: 22959104 [Abstract] [Full Text] [Related]
10. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study. Souied EH, Delcourt C, Querques G, Bassols A, Merle B, Zourdani A, Smith T, Benlian P, Nutritional AMD Treatment 2 Study Group. Ophthalmology; 2013 Aug; 120(8):1619-31. PubMed ID: 23395546 [Abstract] [Full Text] [Related]
11. Effects of vitrectomy on age-related macular degeneration. Roller AB, Mahajan VB, Boldt HC, Abramoff MD, Russell SR, Folk JC. Ophthalmology; 2010 Jul; 117(7):1381-6. PubMed ID: 20176401 [Abstract] [Full Text] [Related]
12. Long-Term Results of Full Macular Translocation for Choroidal Neovascularization in Age-Related Macular Degeneration. van Romunde SH, Polito A, Bertazzi L, Guerriero M, Pertile G. Ophthalmology; 2015 Jul; 122(7):1366-74. PubMed ID: 25881514 [Abstract] [Full Text] [Related]
13. Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial. Maguire MG, Alexander J, Fine SL, Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. Ophthalmology; 2008 Sep; 115(9):1468-73, 1473.e1-2. PubMed ID: 18486222 [Abstract] [Full Text] [Related]
14. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Sunness JS, Gonzalez-Baron J, Bressler NM, Hawkins B, Applegate CA. Ophthalmology; 1999 May; 106(5):910-9. PubMed ID: 10328389 [Abstract] [Full Text] [Related]
15. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration. Mruthyunjaya P, Stinnett SS, Toth CA. Ophthalmology; 2004 Sep; 111(9):1715-24. PubMed ID: 15350328 [Abstract] [Full Text] [Related]
17. Long-term follow-up of full macular translocation for choroidal neovascularization. Yamada Y, Miyamura N, Suzuma K, Kitaoka T. Am J Ophthalmol; 2010 Mar; 149(3):453-7.e1. PubMed ID: 20035923 [Abstract] [Full Text] [Related]
18. Clinical characteristics of reticular pseudodrusen in the fellow eye of patients with unilateral neovascular age-related macular degeneration. Hogg RE, Silva R, Staurenghi G, Murphy G, Santos AR, Rosina C, Chakravarthy U. Ophthalmology; 2014 Sep; 121(9):1748-55. PubMed ID: 24856310 [Abstract] [Full Text] [Related]
19. Full macular translocation following photodynamic therapy in neovascular age-related macular degeneration. Suesskind D, Voelker M, Bartz-Schmidt KU, Gelisken F. Eye (Lond); 2008 Jun; 22(6):834-7. PubMed ID: 17401325 [Abstract] [Full Text] [Related]
20. Prophylactic treatment of age-related macular degeneration report number 2: 810-nanometer laser to eyes with drusen: bilaterally eligible patients. Friberg TR, Brennen PM, Freeman WR, Musch DC, PTAMD Study Group. Ophthalmic Surg Lasers Imaging; 2009 Jun; 40(6):530-8. PubMed ID: 19928717 [Abstract] [Full Text] [Related] Page: [Next] [New Search]